Glivec (imatinib) CML and GIST Treatment Glivec, CML, and GIST Treatment Information for International Healthcare Professionals Glivec, CML and GIST Treatment Information for US Residents International Glivec Information from Novartis Oncology Click here to go to Novartis.com Novartis Oncology International Site
International Glivec Information from Novartis Oncology
Ask a question
Haematology and Oncology News from Glivec.com

Our weekly newsletter keeps you informed of the latest haematology and oncology news.

"Feedback" Survey

Your Opinion is Very Important to Us

Your answers to this important survey will help us to make Glivec.com an even better resource for you. We truly appreciate your input-and we invite you to visit the Glivec Web site again.

 
1.    Why did you visit www.Glivec.com today?
 To learn about CML  
 To learn about GIST  
 To obtain Glivec information  
 To get information for my patients  
 To get reimbursement assistance  
 To learn about the GIPAP program  
 
2.    Did the content of the site fulfill your need?
Yes   
No   
 
3.    How easy was it to find the information you were looking for?
Very Easy   
Easy   
Neither easy or difficult   
Difficult   
Very difficult   
 
4.    What sections did you find the most interesting? (Check all that apply )
 About Glivec  
 CML  
 GIST  
 For Your Patients  
 News   
 Resources  
 EU SmPC  
 None of the above  
 
5.    Would you visit www.Glivec.com again?
Yes   
No   



 

Disclaimer: This is an international website for Glivec (imatinib) and is intended for healthcare professionals outside the US. If you are a US resident, please click on the For US Residents link at the top of this page. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.



Use of this website is subject to our Terms of Use.
© 2008 Novartis Pharma AG